Clinical and Translational Radiation Oncology

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV Erik De Clercq International Journal of Antimicrobial Agents Volume 33,
Port-site recurrence in a patient undergoing robotic hysterectomy and lymph node dissection for endometrioid adenocarcinoma of the uterus Ioannis Alagkiozidis,
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
A review of patterns of practice and clinical guidelines in the palliative radiation treatment of uncomplicated bone metastases  Vithusha Ganesh, Stephanie.
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism  Lilit Petrosyan  Journal.
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey  Lazzaro Repetto  Critical.
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.
Radiation Therapy and Hearing Loss
Preoperative endorectal brachytherapy in the treatment of locally advanced rectal cancer: Rethinking neoadjuvant treatment  Matthew C. Biagioli, MD, MS,
Volume 122, Issue 3, Pages (March 2002)
Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the.
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma  M. Ashton, N. O'Rourke, N.
Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer  Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson,
Clinical and Translational Radiation Oncology
When fasted is not empty: a retrospective cohort study of gastric content in fasted surgical patients†   P Van de Putte, L Vernieuwe, A Jerjir, L Verschueren,
Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases  Edward Chow, MBBS, Lori Davis, PhD, Lori Holden,
Volume 148, Issue 1, Pages (January 2018)
P.-S. Hsu, H.-H. Lin, C.-R. Li, W.-S. Chung 
Retrospective assessment of MRI-based volumetric changes of normal tissues in glioma patients following radio(chemo)therapy  Andreas Gommlich, Felix Raschke,
Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians)  Carsten Nieder, Thomas A.
Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer
Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era  Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,
Adjuvant chemotherapy for rectal cancer – Authors' reply
VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure  G. Lazzari, A. Terlizzi,
Volume 62, Issue 3, Pages (March 2015)
Volume 26, Issue 2, Pages (February 2018)
Clinical and Translational Radiation Oncology
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.
Epidemiology of opportunistic infections in AIDS patients
Jojanneke M. Seinen, Maarten G
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer  E.N. Prendergast,
R Wengritzky, T Mettho, P.S. Myles, J Burke, A Kakos 
Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer  Sweet Ping.
Survival and failure types after radiation therapy of vulvar cancer
Practice Notes from the AAAAI
A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: A secondary analysis of a prospective.
Radiomic analysis in prediction of Human Papilloma Virus status
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center 
Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated.
Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012  A.C.E.
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study  V.
Jean-Emmanuel Bibault, Ingeborg Tinhofer 
Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma 
What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor.
Impact of an evidence-based guideline on the management of community-acquired bacterial meningitis: a prospective cohort study  J.M. Costerus, M.C. Brouwer,
Antibiotic De-Escalation
Statin use and clinical outcomes among pneumonia patients
The posterior cerebellum, a new organ at risk?
Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas  Debra Nana Yeboa, James B. Yu,
Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy)
Shorter duration of antibiotic treatment for acute bacteraemic cholangitis with successful biliary drainage: a retrospective cohort study  A. Doi, T.
Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients  Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review  Tetsuo Saito,
68-Year-Old Man With Chronic Diarrhea, Nausea, and Vomiting
Aisling Krishnan, Yat Man Tsang, Adéle Stewart-Lord 
Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists  Jennifer Strijbos,
Practice Notes from the AAAI
Volume 4, Issue 3, Pages (March 2018)
Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer  D. Zylla, M.A. Kuskowski, K. Gupta, P. Gupta 
Clinical and Translational Radiation Oncology
Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy  Mercy Ofuya, Lucy McParland, Louise Murray,
Presentation transcript:

Clinical and Translational Radiation Oncology A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil- based chemotherapy for rectal adenocarcinoma  Kristopher Dennis, Liang Zeng, Carlo De Angelis, Hans Chung, Natalie Coburn, Edward Chow, C. Shun Wong  Clinical and Translational Radiation Oncology  Volume 10, Pages 42-46 (March 2018) DOI: 10.1016/j.ctro.2018.04.001 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 The number of days that each of the 7 affected patients reported vomiting during the entire study period. Each segment represents an individual patient’s days. Clinical and Translational Radiation Oncology 2018 10, 42-46DOI: (10.1016/j.ctro.2018.04.001) Copyright © 2018 The Authors Terms and Conditions

Fig. 2 Percentage of patients reporting vomiting and retching and nausea per day within the during-RT period. RT = radiation therapy. Clinical and Translational Radiation Oncology 2018 10, 42-46DOI: (10.1016/j.ctro.2018.04.001) Copyright © 2018 The Authors Terms and Conditions